Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while YieldMax Universe Fund of Option Income ETFs trades at $7.62 (market cap $364M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 34.6× YieldMax Universe Fund of Option Income ETFs's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and YieldMax Universe Fund of Option Income ETFs for 56 Days on average.
| HALO | YMAX | |
|---|---|---|
Market Cap | $12.58B | $364M |
Volume | 2,179,278 | 1,181,378 |
Sector | Health | Income / Options Overlay |
52-Week High | $115.22 | $12.98 |
52-Week Low | $61.63 | $7.27 |
Typical Hold Time | 1 Days | 56 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YMAX trades at $7.61, up 1.06% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF maintains a high distribution yield, paying weekly dividends, though recent news highlights concerns about net asset value erosion. Key support is at $7, with resistance at $8.
The outlook is cautious due to structural risks from the fund-of-funds fee structure and declining share price despite distributions. Opportunities exist for income-focused investors seeking high yield, but principal erosion remains a significant risk. Analyst sentiment is neutral to bearish, emphasizing sustainability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
